2022 Fiscal Year Final Research Report
Gut microbiome Candida as a new pathophysiological causative factor of intractable eosinophilic chronic rhinosinusitis
Project/Area Number |
19K09917
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 56050:Otorhinolaryngology-related
|
Research Institution | Nippon Medical School |
Principal Investigator |
MATSUNE Shoji 日本医科大学, 医学部, 教授 (00253899)
|
Co-Investigator(Kenkyū-buntansha) |
大橋 隆治 日本医科大学, 医学部, 准教授 (00328783)
吾妻 安良太 日本医科大学, 医学部, 教授 (10184194)
大久保 公裕 日本医科大学, 大学院医学研究科, 大学院教授 (10213654)
若林 あや子 日本医科大学, 医学部, 講師 (30328851)
若山 望 日本医科大学, 大学院医学研究科, 非常勤講師 (90813238)
|
Project Period (FY) |
2019-04-01 – 2023-03-31
|
Keywords | 好酸球性鼻副鼻腔炎 / type 2炎症 / 腸内フローラ / カンジダ / 皮内テスト / 遅延型過敏反応 |
Outline of Final Research Achievements |
Eosinophilic chronic rhinosinusitis (ECRS)is an intractable upper airway inflammatory disease that is often complicated with bronchial asthma. Type 2 inflammation consisted of innate immunity and helper T2 -mediated allergy has been regarded as the pathophysiology of ECRS. However, it remains unclear why only some individuals develop ECRS with type 2 inflammation when they inhale common air components that irritate the sinus mucosa. In our present study, we hypothesized that there is more Candida in the gut microbiome in patients with ECRS more often than in patients with NECRS. This hypothesis was assessed with stool samples from all patients with ECRS and NECRS before surgery. A Candida-selective CHROM CANDIDA Ⅱ agar medium system was used for this assessment. Candida in stool was statistically more common in patients with ECRS than in patients with NECRS. Dysbiosis of the gut microbiome, such as an increase in Candida, was concluded to be an important causative factor of ECRS.
|
Free Research Field |
耳鼻咽喉科
|
Academic Significance and Societal Importance of the Research Achievements |
腸内フローラにおけるカンジダの増加が、好酸球性鼻副鼻腔炎病態に関与している可能性がある。腸内フローラにおけるカンジダの増加が、難治性鼻府K鼻腔炎の副鼻腔粘膜局所での type 2 炎症の全身レベルでのpredisposing factorになっている可能性があり、本疾患の 病態論に基づく、予防、診断、治療を大きく変える可能性がある。
|